Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT00642213 |
Other study ID # |
UC IRB 2013-3959 |
Secondary ID |
R01NS030678 |
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
July 1993 |
Est. completion date |
April 1, 2025 |
Study information
Verified date |
May 2023 |
Source |
University of Cincinnati |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and
outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom
215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention,
and evaluation of public health efforts to decrease the mortality and morbidity due to stroke
in the United States.
We have completed this goal for 1993-94, 1999, 2005, 2010 and 2015. We are in the process of
collecting this data for 2020. In the 2020 study period we will also be ascertaining 3 year
recurrence rates for all incident stroke events.
Description:
For calendar years 1993-94, 1999, 2005, 2010, 2015, and 2020 we will or have identified every
hospitalized or autopsied stroke and transient ischemic attack (TIA) at all regional
hospitals in our region. We will also estimate the number of non-hospitalized strokes and
TIAs by screening for potential cases at more than 100 outpatient sites throughout five
counties in Greater Cincinnati/Northern Kentucky. We plan to identify and abstract detailed
information from the medical record for every potential case. These results will be compared
with data from all stroke patients identified by similar methodology in all study periods.
In addition, we have interviewed 1500 ischemic stroke patients and/or their families in the
study periods 1999-2010 to obtain detailed information including demographic information,
functional outcome and quality of life, access to and type of rehabilitation therapy, social
support, caregiver availability and health status, access to post-hospital care, health
insurance status, current health status, medications, prior risk factors, and knowledge about
stroke signs and symptoms. We also obtained genetic material via a blood sample for most of
this cohort.